TAMPA, Fla., Feb. 15, 2018 -- Foresight Medical, LLC, a leading provider of surgical and implant cost-containment services, today announced ForeSight and Encompass applications have earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization’s ForeSight and Encompass applications have met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places ForeSight Medical, LLC in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
“Achieving HITRUST CSF Certification is a great accomplishment for ForeSight Medical and demonstrates ForeSight Medical’s and Encompass Specialty Surgical Network’s applications maintain the security, confidentiality and integrity of our client’s data,” said Alisa Lewis, Director of Regulatory Compliance. “The HITRUST CSF is the gold-standard that needs to be met, and we are pleased to be able to show our commitment by achieving HITRUST CSF Certification.”
“As we have earned recognition for compliance in HIPAA, Hi-Tech, ISO 27001, SOC 2, and now HITRUST, there is no doubt that ForeSight’s dedication to the integrity and confidentiality of our systems is deeply ingrained in our company culture,” said Bill Elliott, Chief Operating Officer.
“The HITRUST CSF has become the information protection framework for the healthcare industry, and the CSF Assurance program is bringing a new level of effectiveness and efficiency to third-party assurance,” said Ken Vander Wal, Chief Compliance Officer, HITRUST. “The HITRUST CSF Certification is now the benchmark that organizations required to safeguard PHI are measured against with regards to information protection.”
About ForeSight Medical, LLC
ForeSight Medical is built on the idea that delivering better outcomes, quality care and administrative ease requires a profound understanding of the unique nuances surrounding surgeons, site of care dynamics, the implantable device supply chain and widely variable provider reimbursement practices. ForeSight Medical, a surgical and implantable device management organization, does just that – propelled by a team that draws on significant firsthand experience in the Ambulatory Surgical Center and Implantable Device industry. ForeSight delivers impactful results and enhances patient satisfaction through the use of mined surgical data and actionable analytics, cost containment strategies, and a true appreciation for the intricate and intersecting worlds of the medical community and Workers’ Compensation payers.
ForeSight Medical, LLC Media Contact:
Alisa Lewis
ForeSight Medical, LLC
[email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



